Mirae Asset Global Investments Co., Ltd. Igm Biosciences, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,136 shares of IGMS stock, worth $1,715. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,136Holding current value
$1,715% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IGMS
# of Institutions
83Shares Held
20.7MCall Options Held
68KPut Options Held
52.2K-
Baker Bros. Advisors LP New York, NY4.09MShares$6.18 Million0.72% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.01MShares$6.06 Million0.01% of portfolio
-
Siren, L.L.C. New York, NY3.33MShares$5.03 Million2.75% of portfolio
-
Redmile Group, LLC San Francisco, CA3.07MShares$4.64 Million3.32% of portfolio
-
Goldman Sachs Group Inc New York, NY1.26MShares$1.9 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $43.7M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...